Home > Healthcare > Medical Devices > Diagnostic Devices > PCR & NGS Based Diagnostic Testing Market

PCR & NGS Based Diagnostic Testing Market Share

Report ID: GMI5057
Published Date: May 2021
Report Format: PDF

Download Free Sample

PCR & NGS Based Diagnostic Testing Market Share

Some of the key companies functioning in the PCR & NGS based diagnostic testing market include

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
Eppendorf AG
Fluotics
Hamilton Company
Illumina, Inc.
Integra LifeScience Holdings Corporation
MGI Tech Co., Ltd
Mascon, Inc.
Qiagen Inc
Roche Diagnostics
Thermo Fisher Scientific
Thomas Scientific (The Carlyle Group)
VWR International (Avantor, Inc.)

These industry leaders have been undergoing strategic developments to sustain the market competition and capture sizable revenue share in the testing industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The industry share of PCR & NGS based diagnostic testing was valued at USD 21.5 billion in 2020 and will expand with higher usage in the detection of viruses and other infectious diseases.

The industry revenue from consumable products had reached USD 18.8 billion in 2020 and will grow in the coming years owing to the increasing adoption of disposable products in the PCR and NGS based diagnostic testing.

Diagnostic centers accounted for over 36% of the PCR & NGS based diagnostic testing market share in 2020 and will observe growth due to the presence of latest technologies and apt medical infrastructure.

North America PCR & NGS based diagnostic testing market size is pegged to strike a 1.2% growth rate up to 2027 driven by the rising sales of consumables in the region.